The market has been high on Organogenesis Holdings Inc (ORGO) stock recently. ORGO gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ORGO Stock Today?
Organogenesis Holdings Inc (ORGO) stock is trading at $21.34 as of 11:28 AM on Tuesday, May 4, a drop of -$1.89, or -8.14% from the previous closing price of $23.23. The stock has traded between $21.06 and $23.74 so far today. Volume today is below average. So far 371,789 shares have traded compared to average volume of 784,959 shares.
To see the top 5 stocks in the Drug Manufacturers - Specialty & Generic industry click here.
More About Organogenesis Holdings Inc
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Click Here to get the full Stock Score Report on Organogenesis Holdings Inc (ORGO) Stock.